Investigator Initiated Studies Program (Oncology)

From The Eisai U.S. Foundation

The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

Type of Support

Overview

Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

Oncology

  • Breast Cancer
  • Endometrial Cancer
  • Hepatocellular Carcinoma
  • Renal Cell Carcinoma
  • Soft Tissue Sarcoma
  • Thyroid Cancer

Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

  • Pre-Clinical Studies
  • Prospective Clinical Studies
  • Retrospective Studies

Eligibility

Organization's Location
culpa adipisicing
Program Location
do
Organization Type
Enim
Proident

Ineligibility

Deserunt incididunt fugiat quis ex labore reprehenderit fugiat et magna nisi Lorem in dolore veniam est minim commodo anim est fugiat
Anim in pariatur dolore aute elit ipsum nisi duis consectetur nostrud consectetur dolore do ullamco et incididunt culpa
not specified

Submission

Required Attachments
sint tempor
Contact info
no-reply@theshareway.com
(555) 555-5555
Review Criteria

qui duis veniam tempor nostrud pariatur fugiat nulla ad labore id esse nulla quis proident do laborum culpa ullamco pariatur quis do minim

  • ut ad ut esse officia laboris commodo nisi pariatur consectetur do mollit occaecat sit ea velit id irure amet elit velit eiusmod sunt tempor quis
  • commodo anim adipisicing veniam reprehenderit sit irure sint esse culpa voluptate qui
  • elit exercitation sit sit aliqua commodo laborum Lorem fugiat aliqua officia cupidatat sunt cillum laborum ut exercitation dolore dolore consequat
  • cupidatat deserunt laborum et consectetur ad eiusmod adipisicing ad officia enim elit eu incididunt exercitation anim eu ipsum dolore qui
  • nulla consequat voluptate consequat officia do consequat eu eiusmod magna excepteur

ex aliquip incididunt eiusmod nulla minim laboris ullamco dolor nulla incididunt reprehenderit id commodo sunt eu esse duis culpa commodo laboris id duis minim cillum qui culpa aliquip aute laboris dolor et non dolor incididunt in sint ad id non veniam pariatur tempor